Cargando…
Neuropsychiatric Complications of COVID-19
PURPOSE OF REVIEW: To describe the presentation, etiologies, and suggested management of post-acute COVID-19 neuropsychiatric symptoms. RECENT FINDINGS: Over 30% of patients hospitalized with COVID-19 may exhibit cognitive impairment, depression, and anxiety that persist for months after discharge....
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962429/ https://www.ncbi.nlm.nih.gov/pubmed/33725218 http://dx.doi.org/10.1007/s11920-021-01237-9 |
_version_ | 1783665467628453888 |
---|---|
author | Nakamura, Zev M. Nash, Rebekah P. Laughon, Sarah L. Rosenstein, Donald L. |
author_facet | Nakamura, Zev M. Nash, Rebekah P. Laughon, Sarah L. Rosenstein, Donald L. |
author_sort | Nakamura, Zev M. |
collection | PubMed |
description | PURPOSE OF REVIEW: To describe the presentation, etiologies, and suggested management of post-acute COVID-19 neuropsychiatric symptoms. RECENT FINDINGS: Over 30% of patients hospitalized with COVID-19 may exhibit cognitive impairment, depression, and anxiety that persist for months after discharge. These symptoms are even more common in patients who required intensive care for severe effects of the virus. In addition to the pandemic-related psychological stress, multiple biological mechanisms have been proposed to understand the neuropsychiatric symptoms observed with COVID-19. Given limited research regarding effective interventions, we recommend pharmacologic and behavioral strategies with established evidence in other medically-ill populations. SUMMARY: Long-term, neuropsychiatric complications of COVID-19 are common and consequential. Because these are likely to co-occur with other medical problems, patients recovering from COVID-19 are best managed in clinics with highly coordinated care across disciplines and medical specialties. Future research is needed to inform appropriate interventions. |
format | Online Article Text |
id | pubmed-7962429 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-79624292021-03-16 Neuropsychiatric Complications of COVID-19 Nakamura, Zev M. Nash, Rebekah P. Laughon, Sarah L. Rosenstein, Donald L. Curr Psychiatry Rep Psychiatry in Primary Care (BN Gaynes, Section Editor) PURPOSE OF REVIEW: To describe the presentation, etiologies, and suggested management of post-acute COVID-19 neuropsychiatric symptoms. RECENT FINDINGS: Over 30% of patients hospitalized with COVID-19 may exhibit cognitive impairment, depression, and anxiety that persist for months after discharge. These symptoms are even more common in patients who required intensive care for severe effects of the virus. In addition to the pandemic-related psychological stress, multiple biological mechanisms have been proposed to understand the neuropsychiatric symptoms observed with COVID-19. Given limited research regarding effective interventions, we recommend pharmacologic and behavioral strategies with established evidence in other medically-ill populations. SUMMARY: Long-term, neuropsychiatric complications of COVID-19 are common and consequential. Because these are likely to co-occur with other medical problems, patients recovering from COVID-19 are best managed in clinics with highly coordinated care across disciplines and medical specialties. Future research is needed to inform appropriate interventions. Springer US 2021-03-16 2021 /pmc/articles/PMC7962429/ /pubmed/33725218 http://dx.doi.org/10.1007/s11920-021-01237-9 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Psychiatry in Primary Care (BN Gaynes, Section Editor) Nakamura, Zev M. Nash, Rebekah P. Laughon, Sarah L. Rosenstein, Donald L. Neuropsychiatric Complications of COVID-19 |
title | Neuropsychiatric Complications of COVID-19 |
title_full | Neuropsychiatric Complications of COVID-19 |
title_fullStr | Neuropsychiatric Complications of COVID-19 |
title_full_unstemmed | Neuropsychiatric Complications of COVID-19 |
title_short | Neuropsychiatric Complications of COVID-19 |
title_sort | neuropsychiatric complications of covid-19 |
topic | Psychiatry in Primary Care (BN Gaynes, Section Editor) |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962429/ https://www.ncbi.nlm.nih.gov/pubmed/33725218 http://dx.doi.org/10.1007/s11920-021-01237-9 |
work_keys_str_mv | AT nakamurazevm neuropsychiatriccomplicationsofcovid19 AT nashrebekahp neuropsychiatriccomplicationsofcovid19 AT laughonsarahl neuropsychiatriccomplicationsofcovid19 AT rosensteindonaldl neuropsychiatriccomplicationsofcovid19 |